Companies/Microbix Biosystems Inc.

Company profile

Microbix Biosystems Inc.

OTC: MBXBF · Healthcare · Biotechnology

Canadian filerHQ Mississauga, ONReports USD

#593 of 1,394 Healthcare companies by revenuebottom-quartile growth

EA Score

59C

FH 68DQ —GM 38SS 46

v0.1 · 45/100 weight · provisional

↑ balance-sheet leverage, return on assets · ↓ listing tenure, revenue growth (YoY)

Methodology →

Revenue TTM

$10.7M

Rev growth YoY (TTM)

-34.4%

Net income (FY)

-$1.6M

Employees

100

Market cap

$29.7M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$13.3M18.6M CAD2025

Net income-$1.6M-2.2M CAD2025

Operating income-$1.1M-1.6M CAD2025

Total assets$26.9M37.5M CAD2025

Liabilities$6.9M9.6M CAD2025

Equity$20.0M27.8M CAD2025

Revenue trend

FY2018 – FY2025 · USD

$9.7M

FY18

$10.1M

FY19

$7.8M

FY20

$14.7M

FY21

$14.9M

FY22

$12.2M

FY23

$18.7M

FY24

$13.3M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Microbix Biosystems Inc. booked $13.3M in FY2025 revenue, contracting 29% year over year — slower than 76% of Healthcare companies we track, at a -12.1% net margin.

Peers · Healthcare

HST Global, Inc.——High Sierra Technologies, Inc.——MapLight Therapeutics, Inc.——Cingulate Inc.——

Key facts

CEOCameron L. Groome

SectorHealthcare

IndustryBiotechnology

HeadquartersMississauga, ON

ExchangeOTC: MBXBF

Employees100

IPO date2021-01-08

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.